In human breast cancer MCF7 cells, low doses of radiation inhibit doxorubicin-induced replicative senescence by suppressing p38-dependent p53 phosphorylation and activating ERK1/2, without genomic damage [169]. The gene discussed is TP53; the disease is breast carcinoma.